SATB1 and breast carcinoma: In some studies, the expression level of SATB1 correlated with cancer progression and was suggested to be an useful prognostic marker in breast cancer, laryngeal squamous cell carcinoma, cutaneous melanoma, glioma, gastric, and hepatocellular cancer [3, 5–7, 10].